跳至主要内容
临床试验/NCT01507935
NCT01507935撤回2 期

Randomised, Controlled, Double-blind Exploratory Study to Investigate the Effect of Specific Prebiotic Oligosaccharides on Gut Microbiota Composition in Healthy Infants

Danone Asia Pacific Holdings Pte, Ltd.2 个研究点 分布在 1 个国家开始时间: 2012年1月最近更新:
适应症

试验速览

阶段
2 期
状态
撤回
试验地点
2
主要终点
Gut microbiota composition and its metabolic activity

研究概览

简要总结

This study is initiated to investigate the effect of infant formulas with added specific prebiotic oligosaccharides on the reduction of specific potential pathogens and/or toxins.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
8 Weeks 至 10 Weeks(Child)
性别
All
接受健康志愿者

入选标准

  • Healthy term infants (gestational age 37 to 42 weeks) aged 2-2.5 months at inclusion
  • Fully formula fed for at least one week (not applicable for the breastfeeding reference group since these infants must be exclusively breastfed before and throughout the study)
  • Parents' or guardian's written informed consent

排除标准

  • Being weaned before inclusion (introduction of any other foods other than formula or breast milk.)
  • Moderate or severe acute malnutrition, defined as weight-for-age and sex below -2 z-scores of the median WHO growth standards
  • Disorders requiring a special diet (such as food intolerance or food allergy or complaints such as reflux, constipation and cramps)
  • Significant congenital abnormality that could affect the study results
  • Use of systemic antibiotics or anti-mycotic drugs in the 4 weeks preceding the study
  • Investigator's uncertainty about the willingness or ability of the parents to comply with the protocol requirements
  • Participation in any other studies involving investigational or marketed products concomitantly or within two weeks prior to entry into the study
  • Gastroenteritis in the last two weeks before inclusion

结局指标

主要结局

Gut microbiota composition and its metabolic activity

时间窗: Week 6

* Gut microbiota composition: count and/or proportion and/or prevalence of group/genus/species of bacteria in the gut * Metabolic activity of the gut microbiota: pH, SCFA, lactate

次要结局

  • Number, type and severity of (serious) adverse events(Week 1, Week 3, Week 6, Week 8)
  • Gastrointestinal symptoms (incidence and severity)(Week 1, Week 3, Week 6, Week 8)
  • Anthropometry(Week 1, Week 3, Week 6, Week 8)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Colonisation Resistance Study | 临床试验